GAEU Ventures has invested in Developeration AB, a Swedish medtech company known for its innovative hemorrhoid treatment solution, PexyEazy®, which significantly reduces costs and enhances patient recovery.
Target Information
Developeration AB, a Swedish medtech company founded in 2016, specializes in innovative treatment methodologies for hemorrhoids. The company has developed the PexyEazy® instrument, which offers a novel surgical technique that alleviates the common ailment of hemorrhoids with significant advancements in patient recovery.
Utilizing PexyEazy®, hemorrhoid treatment can be conducted without anesthesia, resulting in considerably less pain and discomfort for the patient post-surgery. Furthermore, the treatment cost associated with PexyEazy® is estimated to be up to 70% lower than that of conventional methods.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Sweden
The medtech industry in Sweden is renowned for its robust ecosystem that fosters innovation and research. With a strong focus on technological advancement and healthcare solutions, Sweden stan
Similar Deals
GAEU Ventures
invested in
Developeration AB
in 2023
in a Other VC deal